Placemark Investments’s Bristol-Myers Squibb BMY Stock Holding History

Placemark Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$7.38M	Sell	124,997 -4,950	-4%	-$279K	0.13%	198
2014 Q3	$6.65M	Buy	129,947 +12,675	+11%	+$633K	0.12%	205
2014 Q2	$5.69M	Buy	117,272 +12,874	+12%	+$634K	0.1%	248
2014 Q1	$5.42M	Sell	104,398 -3,789	-4%	-$202K	0.1%	221
2013 Q4	$5.75M	Buy	108,187 +40,820	+61%	+$2.08M	0.09%	252
2013 Q3	$3.12M	Sell	67,367 -17,013	-20%	-$747K	0.06%	375
2013 Q2	$3.77M	Buy	+84,380	New	+$3.66M	0.08%	290

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Placemark Investments's BMY Position: Q4 2014 in Review

Placemark Investments reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q4 2014, selling an estimated $279K and leaving 124,997 shares worth $7.38M. The position accounts for 0.13% of the portfolio, ranked #198.

Placemark Investments first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. 1,410 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

Placemark Investments held 124,997 shares of Bristol-Myers Squibb worth $7.38M as of Q4 2014.
Placemark Investments sold 4,950 Bristol-Myers Squibb shares in Q4 2014, an estimated $279K.
Bristol-Myers Squibb made up 0.13% of Placemark Investments's portfolio in Q4 2014, its #198 holding.
Placemark Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
1,410 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.